Refractory oncology
WebApr 1, 2016 · OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats. WebMar 17, 2024 · The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI) significantly improved overall survival (OS) and progression-free survival (PFS) compared with FTD/TPI as a single agent in patients with refractory metastatic colorectal cancer (mCRC), representing a novel standard-of-care for patients …
Refractory oncology
Did you know?
WebDec 1, 2024 · What are relapsed and refractory diseases? Relapsed disease means a cancer has come back. Refractory disease means a cancer has stopped responding to treatment. … WebFeb 20, 2024 · Holkova B, Supko JG, Ames MM, et al. A phase i trial of vorinostat and alvocidib in patients with relapsed, refractory or poor prognosis acute leukemia, or …
WebJan 31, 2024 · The word “refractory” in general use means stubborn or intractable, and in medicine it is specifically applied to disease that does not respond to treatment. Refractory cancer refers to cancer that may be resistant at the beginning of treatment, or becomes … WebSep 11, 2024 · Immunotherapy (IO) has revolutionized the therapy landscape of non-small cell lung cancer (NSCLC), significantly prolonging the overall survival (OS) of advanced stage patients. Over the recent years IO therapy has been broadly integrated into the first-line setting of non-oncogene driven NSCLC, either in combination with chemotherapy, or in …
WebFeb 23, 2024 · Brian I. Rini, MD, discusses standard and investigational treatment options for patients with RCC who are refractory to immunotherapy; the potential role of biomarkers … WebSep 25, 2024 · Chemorefractory is a term used to describe cancer that does not respond to chemotherapy (chemo) medications. 1 Cancer can be refractory to chemotherapy …
WebAug 27, 2024 · Treatment of relapsed or refractory acute myeloid leukemia (AML) has presented challenges for hematologists for decades. Despite numerous clinical studies, outcomes are consistently disappointing with 5-year overall survival rates of ∼10%.
WebEvaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory Cancer Pediatric Cancer JAMA Oncology JAMA Network info on people searchWebApr 11, 2024 · The FDA has granted fast track designation to the investigational allogenic CAR T-cell therapy product CB-011 for the treatment of patients with relapsed or refractory multiple myeloma, according to a press release from Caribou Biosciences, Inc. 1. "Fast track designation for CB-011 allows us instrumental interactions with the FDA as we ... info on newborn kittensWebrefractory cancer: A malignancy for which surgery is ineffective, which is either initially unresponsive to chemo- or radiation therapy, or which becomes unresponsive over time info on peptivaWebApr 27, 2024 · To our knowledge, this was the first prospective study aimed to evaluate the clinical benefit and safety of nivolumab with or without ipilimumab in combination with stereotactic body radiotherapy (SBRT) 15 Gy in patients with refractory metastatic pancreatic cancer who have a poor prognosis and progressive disease. Knowledge … info on people freeWebJan 23, 2024 · Among the 94 patients with high-grade serous ovarian cancer who received treatment in this study, 11 (12%) had primary platinum-refractory disease, an … info on old baby carriagesWebApr 14, 2024 · 20 participants are expected to be enrolled for this open，Single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, … info on olivia newton johnWebRegorafenib is a small-molecule agent that works on multiple levels, targeting kinases, multiple vascular endothelial growth factor (VEGF) receptors, fibroblast growth factor … info on pc